DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy
NCT ID: NCT04825795
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4007 participants
OBSERVATIONAL
2010-01-01
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects
NCT00961025
Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
NCT04439474
A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men
NCT00347542
Effects of Selenium Towards Type 2 Diabetes
NCT06457984
A Clinical Trial to Evaluate the Food Effect of CKD-379
NCT06652971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DPP4-inhibitor
Patients who were prescribed DPP4-inhibitor during the period between two coronary CT scan.
DPP4-inhibitor
Prescription of DPP4-inhibitor during the period between the two coronary CT scan
No DPP4-inhibitor
Patients who were not prescribed DPP4-inhibitor during the period between two coronary CT scan.
No DPP4-inhibitor
No prescription of DPP4-inhibitor during the period between the two coronary CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DPP4-inhibitor
Prescription of DPP4-inhibitor during the period between the two coronary CT scan
No DPP4-inhibitor
No prescription of DPP4-inhibitor during the period between the two coronary CT scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving chronic insulin therapy (prescription of insulin pen)
* Who underwent more than 2 times of coronary CT scan
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang Hyun Ihm, MD PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sang-Hyun Ihm, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bucheon St. Mary's Hospital
Bucheon-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XC21WIDI0044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.